These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 325514)

  • 21. Cardiac retransplantation: is it justified in times of critical donor organ shortage? Long-term single-center experience.
    Goerler H; Simon A; Gohrbandt B; Hagl C; Oppelt P; Haverich A; Strueber M
    Eur J Cardiothorac Surg; 2008 Dec; 34(6):1185-90. PubMed ID: 18693029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac transplantation: current status.
    Cooper T; Mitchell SC
    Transplant Proc; 1969 Jun; 1(2):755-7. PubMed ID: 4939674
    [No Abstract]   [Full Text] [Related]  

  • 23. Human heart transplantation.
    Suri RK; Yao JK; Wilson JK; Baker CB
    J Indian Med Assoc; 1972 Apr; 58(7):233-8. PubMed ID: 4558339
    [No Abstract]   [Full Text] [Related]  

  • 24. Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the transplant waiting list; Implications for donor selection criteria.
    Lietz K; John R; Mancini DM; Edwards NM
    J Am Coll Cardiol; 2004 May; 43(9):1553-61. PubMed ID: 15120811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of gender on allograft rejection in a rat heart transplant model.
    Takami H; Backer CL; Crawford SE; Zales VR; Mavroudis C
    J Heart Lung Transplant; 1995; 14(3):529-36. PubMed ID: 7654736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in coronary blood flow during rejection of the orthotopically transplanted canine heart.
    Stinson EB; Griepp RB; Bieber CP; Shumway NE
    J Thorac Cardiovasc Surg; 1972 Jun; 63(6):854-64. PubMed ID: 4555049
    [No Abstract]   [Full Text] [Related]  

  • 27. Hemodynamic observations in the early period after human heart transplantation.
    Stinson EB; Caves PK; Griepp RB; Oyer PE; Rider AK; Shumway NE
    J Thorac Cardiovasc Surg; 1975 Feb; 69(2):264-70. PubMed ID: 1089847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human heart transplantation.
    Yao JK
    Can J Surg; 1973 Mar; 16(2):67-76. PubMed ID: 4570268
    [No Abstract]   [Full Text] [Related]  

  • 29. Functions of canine lung allografts.
    Garzon AA; Dutta SK; Okadigwe C; Paley N; Goldstein S; Minkowitz S; Karlson KE
    J Thorac Cardiovasc Surg; 1973 Jan; 65(1):76-87. PubMed ID: 4566044
    [No Abstract]   [Full Text] [Related]  

  • 30. Factors affecting survival after heterotopic heart transplantation.
    Kawaguchi A; Gandjbakhch I; Pavie A; Muneretto C; Bors V; Leger P; Cabrol A; Desruennes M; Cabrol C
    J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 2):928-34. PubMed ID: 2811423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific inhibition of organ allograft rejection by donor blood.
    Marquet RL; Heystek GA; Tinbergen WJ
    Transplant Proc; 1971 Mar; 3(1):708-10. PubMed ID: 4937963
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiac transplantation.
    Burdine J; Fischel RJ; Bolman RM
    Crit Care Clin; 1990 Oct; 6(4):927-45. PubMed ID: 2265387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The present status of heterotopic cardiac transplantation.
    Barnard CN; Barnard MS; Cooper DK; Curchio CA; Hassoulas J; Novitsky D; Wolpowitz A
    J Thorac Cardiovasc Surg; 1981 Mar; 81(3):433-9. PubMed ID: 7007744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunologic mechanisms of cardiac transplant rejection.
    Duquesnoy RJ; Cramer DV
    Cardiovasc Clin; 1990; 20(2):87-103. PubMed ID: 2404607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does donor and recipient sex influence the development of cardiac allograft vasculopathy?
    Mehra MR; Ventura HO; Escobar A; Cassidy CA; Smart FW; Stapleton DD
    Transplant Proc; 1995 Jun; 27(3):1926-9. PubMed ID: 7792839
    [No Abstract]   [Full Text] [Related]  

  • 36. Transplantation of the heart.
    Griepp RB; Stinson EB; Shumway NE
    Surg Annu; 1976; 8():47-62. PubMed ID: 779073
    [No Abstract]   [Full Text] [Related]  

  • 37. The impact of donor-recipient sex matching on survival after orthotopic heart transplantation: analysis of 18 000 transplants in the modern era.
    Weiss ES; Allen JG; Patel ND; Russell SD; Baumgartner WA; Shah AS; Conte JV
    Circ Heart Fail; 2009 Sep; 2(5):401-8. PubMed ID: 19808369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Independent risk factors predicting acute graft rejection in cardiac transplant recipients treated by triple drug immunosuppression.
    Laufer G; Miholic J; Laczkovics A; Wollenek G; Holzinger C; Hajek-Rosenmeier A; Wuzl G; Schreiner W; Buxbaum P; Wolner E
    J Thorac Cardiovasc Surg; 1989 Dec; 98(6):1113-21. PubMed ID: 2586129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy.
    Lietz K; John R; Beniaminovitz A; Burke EM; Suciu-Foca N; Mancini DM; Edwards NM; Itescu S
    Transplantation; 2003 Mar; 75(6):781-7. PubMed ID: 12660501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of early mortality after heart transplantation: the Canadian transplant experience from 1981 to 1992. The CASCADE Investigators. Canadian Study of Cardiac Transplant Atherosclerosis Determinants.
    Carrier M; Rivard M; Latter D; Kostuk W
    Can J Cardiol; 1998 May; 14(5):703-7. PubMed ID: 9627527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.